Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

SHENZHEN, China , Sept. 19, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), is a technology service provider.

Affinity Bancshares reported strong H1 results, with net interest income up and EPS doubling year-over-year to $0.34 in Q2. AFBI's loan book is heavily weighted toward commercial real estate, with manageable non-accruing loans and strong collateralization in the office segment. The bank's tangible book value stands at $16.80 per share, trading at a reasonable premium and 13-14x annualized H1 earnings.

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”), of the important October 20, 2025 lead plaintiff deadline.

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.

Honeywell's Aerospace Technologies segment posts strong Q2 growth, fueled by commercial aviation and defense demand.

Allegedly, Lineage's IPO filings misrepresented business trends; post-IPO, destocking, leaner inventories, and oversupply drove its stock down ~50%.

What do you do with a stock that rose 23% in a day?

PH acquires Curtis in a $1B deal to boost electrification offerings and expand in material handling and off-highway markets.

Intellia Therapeutics (NTLA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this HIMS commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.

Shake Shack is upgraded to 'buy' after recent stock weakness, with a price target of $125–$130, offering 25–30% upside. SHAK's improved performance is driven by effective new LTOs, market share gains in LA and Denver, and strong restaurant-level profitability. Management reduced construction costs by 10%, boosting ROI per new Shack, while aiming to expand margins through supply chain and labor optimization.

Besides Wall Street's top-and-bottom-line estimates for Cintas (CTAS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended August 2025.